A major discovery in cancer research is arising with the use of mini-antibodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently inactivated in several kinds of malignancies, causing https://social-galaxy.com/story7521985/nanobodies-revive-tumor-suppressor-p53-the-potential-pathway-for-cancer-management